Skip to main content
Top
Published in: Cancer Causes & Control 2/2012

01-02-2012 | Original paper

Adverse events after screening and follow-up colonoscopy

Authors: Carolyn M. Rutter, Eric Johnson, Diana L. Miglioretti, Margaret T. Mandelson, John Inadomi, Diana S. M. Buist

Published in: Cancer Causes & Control | Issue 2/2012

Login to get access

Abstract

Objective

We provide new information about how the risk of adverse events following colonoscopy varies by age and indication (screening vs. follow-up performed to evaluate a positive result from another screening modality).

Methods

We constructed a retrospective cohort comprised of 43,456 individuals aged 40–85 years enrolled in a large integrated healthcare organization in Washington State who underwent outpatient colonoscopy between 1994 and 2009. We calculated rates of serious adverse events (perforation, hemorrhage, and acute diverticulitis) in the 30 days following colonoscopy and compared rates using log-binomial regression models.

Results

We observed 4.7 serious adverse events per 1,000 screening colonoscopies and 6.8 per 1,000 follow-up colonoscopies. Polypectomy increased the rate of serious adverse events (relative rate [RR], 2.64; 95% confidence interval [CI], 1.97–3.56). Older age was associated with increased risk of serious adverse events, after adjusting for polypectomy, gender, and indication. Compared to individuals aged 50–64 years, risk was elevated for those aged 65–74 (RR, 1.93; 95% CI, 1.40–2.65) and 75–85 (RR, 3.21; 95% CI 2.14–4.86). We observed similar age effects in individuals with and without significant comorbid conditions.

Conclusions

The risks of serious adverse events following colonoscopy performed as part of screening are low but increase with age and are more likely after polypectomy.
Appendix
Available only for authorised users
Literature
1.
go back to reference Lieberman D (2010) Progress and challenges in colorectal cancer screening and surveillance. Gastroenterology 138(6):2115–2126 [PMID: 20167216]PubMedCrossRef Lieberman D (2010) Progress and challenges in colorectal cancer screening and surveillance. Gastroenterology 138(6):2115–2126 [PMID: 20167216]PubMedCrossRef
2.
go back to reference Levin B, Lieberman DA, McFarland BG, Andrews KS, Brooks D, Bond J et al (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American cancer society, the US multi-society task force on colorectal cancer, and the american college of radiology. Gastroenterology 134(5):1570–1595 [PMID: 18384785]PubMedCrossRef Levin B, Lieberman DA, McFarland BG, Andrews KS, Brooks D, Bond J et al (2008) Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American cancer society, the US multi-society task force on colorectal cancer, and the american college of radiology. Gastroenterology 134(5):1570–1595 [PMID: 18384785]PubMedCrossRef
3.
go back to reference Whitlock EP, Lin JS, Liles E, Beil TL, Fu R (2008) Screening for colorectal cancer: a targeted, updated systematic review for the US preventive services task force. Ann Intern Med 149(9):638–658 [PMID: 18838718]PubMed Whitlock EP, Lin JS, Liles E, Beil TL, Fu R (2008) Screening for colorectal cancer: a targeted, updated systematic review for the US preventive services task force. Ann Intern Med 149(9):638–658 [PMID: 18838718]PubMed
4.
go back to reference US Preventive Services Task Force (2008) Screening for colorectal cancer: US preventive services task force recommendation statement. Ann Intern Med 149(9):627–637 [PMID: 18838716] US Preventive Services Task Force (2008) Screening for colorectal cancer: US preventive services task force recommendation statement. Ann Intern Med 149(9):627–637 [PMID: 18838716]
5.
go back to reference Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM (2009) American college of gastroenterology guidelines for colorectal cancer screening [corrected]. Am J Gastroenterol 104(3):739–750 [PMID: 19240699]PubMedCrossRef Rex DK, Johnson DA, Anderson JC, Schoenfeld PS, Burke CA, Inadomi JM (2009) American college of gastroenterology guidelines for colorectal cancer screening [corrected]. Am J Gastroenterol 104(3):739–750 [PMID: 19240699]PubMedCrossRef
6.
go back to reference Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN et al (2009) Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116(3):544–573 [PMID: 19998273]CrossRef Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN et al (2009) Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer 116(3):544–573 [PMID: 19998273]CrossRef
7.
go back to reference Schenck AP, Peacock SC, Klabunde CN, Lapin P, Coan JF, Brown ML (2009) Trends in colorectal cancer test use in the medicare population, 1998–2005. Am J Prev Med 37(1):1–7 [PMID: 19423273]PubMedCrossRef Schenck AP, Peacock SC, Klabunde CN, Lapin P, Coan JF, Brown ML (2009) Trends in colorectal cancer test use in the medicare population, 1998–2005. Am J Prev Med 37(1):1–7 [PMID: 19423273]PubMedCrossRef
8.
go back to reference Richardson IC, Rim SH, Plescia M (2010) Vital signs: colorectal cancer screening among adults aged 50–75 years—United States, 2008. MMWR Morb Mortal Wkly Rep 59:808–812 [PMID: 20613704] Richardson IC, Rim SH, Plescia M (2010) Vital signs: colorectal cancer screening among adults aged 50–75 years—United States, 2008. MMWR Morb Mortal Wkly Rep 59:808–812 [PMID: 20613704]
10.
go back to reference Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA et al (2006) Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 145(12):880–886 [PMID: 17179057]PubMed Levin TR, Zhao W, Conell C, Seeff LC, Manninen DL, Shapiro JA et al (2006) Complications of colonoscopy in an integrated health care delivery system. Ann Intern Med 145(12):880–886 [PMID: 17179057]PubMed
11.
go back to reference Singh H, Penfold RB, DeCoster C, Kaita L, Proulx C, Taylor G et al (2009) Colonoscopy and its complications across a Canadian regional health authority. Gastrointest Endosc 69(3 Pt 2):665–671 [PMID: 19251007]PubMedCrossRef Singh H, Penfold RB, DeCoster C, Kaita L, Proulx C, Taylor G et al (2009) Colonoscopy and its complications across a Canadian regional health authority. Gastrointest Endosc 69(3 Pt 2):665–671 [PMID: 19251007]PubMedCrossRef
12.
go back to reference Warren JL, Klabunde CN, Mariotto AB, Meekins A, Topor M, Brown ML et al (2009) Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 150:849–857 [PMID: 19528563]PubMed Warren JL, Klabunde CN, Mariotto AB, Meekins A, Topor M, Brown ML et al (2009) Adverse events after outpatient colonoscopy in the Medicare population. Ann Intern Med 150:849–857 [PMID: 19528563]PubMed
13.
go back to reference Ko CW, Riffle S, Michaels L, Morris C, Holub J, Shapiro JA et al (2010) Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol 8(2):166–173 [PMID: 19850154]PubMedCrossRef Ko CW, Riffle S, Michaels L, Morris C, Holub J, Shapiro JA et al (2010) Serious complications within 30 days of screening and surveillance colonoscopy are uncommon. Clin Gastroenterol Hepatol 8(2):166–173 [PMID: 19850154]PubMedCrossRef
14.
go back to reference Shih YC, Zhao L, Elting LS (2006) Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly? Health Aff (Millwood) 25(4):1153–1162 [PMID: 16835198]CrossRef Shih YC, Zhao L, Elting LS (2006) Does Medicare coverage of colonoscopy reduce racial/ethnic disparities in cancer screening among the elderly? Health Aff (Millwood) 25(4):1153–1162 [PMID: 16835198]CrossRef
15.
go back to reference Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J et al (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124(2):544–560 [PMID: 12557158]PubMedCrossRef Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J et al (2003) Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124(2):544–560 [PMID: 12557158]PubMedCrossRef
16.
go back to reference Rabeneck L, Paszat LF, Hilsden RJ, Saskin R, Leddin D, Grunfeld E et al. (2008) Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 135(6):1899–1906, 1906.e1 [PMID: 18938166] Rabeneck L, Paszat LF, Hilsden RJ, Saskin R, Leddin D, Grunfeld E et al. (2008) Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology 135(6):1899–1906, 1906.e1 [PMID: 18938166]
17.
go back to reference Cheon JH, Kim WH (2007) Recent advances of endoscopy in inflammatory bowel diseases. Gut Liver 1(2):118–125 [PMID: 20485627]PubMedCrossRef Cheon JH, Kim WH (2007) Recent advances of endoscopy in inflammatory bowel diseases. Gut Liver 1(2):118–125 [PMID: 20485627]PubMedCrossRef
18.
go back to reference Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH Jr (1981) A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer 48(12):2742–2745 [PMID: 7306930]PubMedCrossRef Greenstein AJ, Sachar DB, Smith H, Janowitz HD, Aufses AH Jr (1981) A comparison of cancer risk in Crohn’s disease and ulcerative colitis. Cancer 48(12):2742–2745 [PMID: 7306930]PubMedCrossRef
19.
go back to reference Konda A, Duffy MC (2008) Surveillance of patients at increased risk of colon cancer: inflammatory bowel disease and other conditions. Gastroenterol Clin North Am 37(1):191–213, viii [PMID: 18313546] Konda A, Duffy MC (2008) Surveillance of patients at increased risk of colon cancer: inflammatory bowel disease and other conditions. Gastroenterol Clin North Am 37(1):191–213, viii [PMID: 18313546]
20.
go back to reference Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267 [PMID: 11146273]PubMedCrossRef Klabunde CN, Potosky AL, Legler JM, Warren JL (2000) Development of a comorbidity index using physician claims data. J Clin Epidemiol 53(12):1258–1267 [PMID: 11146273]PubMedCrossRef
21.
go back to reference Rutter CM, Yu O, Miglioretti DL (2007) A hierarchical non-homogenous Poisson model for meta-analysis of adenoma counts. Stat Med 26(1):98–109 [PMID: 16372387]PubMedCrossRef Rutter CM, Yu O, Miglioretti DL (2007) A hierarchical non-homogenous Poisson model for meta-analysis of adenoma counts. Stat Med 26(1):98–109 [PMID: 16372387]PubMedCrossRef
22.
go back to reference Sharma VK, Nguyen CC, Crowell MD, Lieberman DA, de Garmo P, Fleischer DE (2007) A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc 66(1):27–34 [PMID: 17591470]PubMedCrossRef Sharma VK, Nguyen CC, Crowell MD, Lieberman DA, de Garmo P, Fleischer DE (2007) A national study of cardiopulmonary unplanned events after GI endoscopy. Gastrointest Endosc 66(1):27–34 [PMID: 17591470]PubMedCrossRef
Metadata
Title
Adverse events after screening and follow-up colonoscopy
Authors
Carolyn M. Rutter
Eric Johnson
Diana L. Miglioretti
Margaret T. Mandelson
John Inadomi
Diana S. M. Buist
Publication date
01-02-2012
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 2/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-011-9878-5

Other articles of this Issue 2/2012

Cancer Causes & Control 2/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine